Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
JACKSONVILLE, Fla., March 09, 2016 -- ParkerVision, Inc. (NASDAQ:PRKR), a leading developer and marketer of radio frequency technologies used in advanced wireless solutions, announced today that the Patent Trial and Appeal Board (“PTAB”) has issued its decisions with regard to the petitions for Inter Partes review (“IPR”) filed by Qualcomm Inc. and Qualcomm Atheros, Inc. (collectively “Qualcomm”) against various claims of three ParkerVision patents.
The PTAB denied all petitions for IPR against the claims Qualcomm challenged for ParkerVision’s U.S. Patent 7,039,372 (the ‘372 Patent). The PTAB instituted the petitions for IPR against the claims challenged for ParkerVision’s U.S. Patent 6,091,940 (the ‘940 Patent) and Patent 7,966,012 (the ‘012 Patent).
The ‘372 and the ‘940 Patent are among the patents asserted in the district court case against Qualcomm, Samsung and HTC (6:14-cv-00687) which is currently stayed pending the results of the Company’s proceedings at the U.S. International Trade Commission. The ‘012 Patent was recently removed from the district court case in a joint agreement between ParkerVision and the defendants in order to narrow the scope of the case.
ParkerVision’s Chairman and CEO, Jeffrey Parker, commented, “We are pleased with the PTAB’s decision to deny institution of IPR proceedings against any of the claims challenged in our ‘372 Patent, including the claims that are asserted as being infringed in our district court case against Qualcomm, Samsung and HTC. It has become common practice for defendants in patent litigation to file IPR challenges with the PTAB against asserted patents with the hopes of invalidating patent claims and therefore avoid infringement. To prevail in a patent lawsuit only a single claim needs to be found infringed and not invalid. We will assess our defense at the PTAB of the other claims for those patents that were instituted for trial.”
About ParkerVision
ParkerVision, Inc. designs, develops and markets its proprietary radio-frequency (RF) technologies, which enable advanced wireless solutions for current and next generation communications networks. Protected by a highly-regarded, worldwide patent portfolio, the Company’s solutions for wireless transfer of RF waveforms address the needs of a broad range of wirelessly connected devices for high levels of RF performance coupled with best-in-class power consumption. For more information please visit www.parkervision.com. (PRKR-G).
Safe Harbor Statement
This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company’s SEC reports, including the Form 10K for the year ended December 31, 2014 and the Forms 10Q for the quarters ended March 31, June 30, and September 30, 2015. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.
Contact: Cindy Poehlman Chief Financial Officer ParkerVision, Inc. 904-732-6100 [email protected] Don Markley The Piacente Group 212-481-2050 [email protected]
